| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004392972 |
| P356 | DOI | 10.1007/S11010-011-1024-X |
| P3181 | OpenCitations bibliographic resource ID | 4862753 |
| P698 | PubMed publication ID | 21858738 |
| P5875 | ResearchGate publication ID | 51587538 |
| P50 | author | Katarina Smiljanic | Q59668063 |
| Tatiana Syrovets | Q64212708 | ||
| P2093 | author name string | Thomas Simmet | |
| Esma R Isenović | |||
| Milan Popović | |||
| Branislava Dobutović | |||
| P2860 | cites work | Inducible secretion of large, biologically potent von Willebrand factor multimers | Q24296142 |
| cPLA2 is phosphorylated and activated by MAP kinase | Q24314148 | ||
| Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque | Q24339425 | ||
| Activation of human factor IX (Christmas factor) | Q24594116 | ||
| Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets | Q28183746 | ||
| The role of PAR4 in thrombin-induced thromboxane production in human platelets | Q28190619 | ||
| Prostaglandins, bioassay and inflammation | Q28194428 | ||
| P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation | Q28194880 | ||
| Intravascular tissue factor pathway--a model for rapid initiation of coagulation within the blood vessel | Q28204622 | ||
| Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation | Q28211291 | ||
| Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140 | Q28237622 | ||
| Role of tissue factor in hemostasis, thrombosis, and vascular development | Q28259220 | ||
| Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells | Q28262222 | ||
| A dual thrombin receptor system for platelet activation | Q28280578 | ||
| The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action | Q28298065 | ||
| MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment | Q28298072 | ||
| Functional prothrombinase complex assembly on isolated monocytes and lymphocytes | Q71766776 | ||
| Endothelins | Q71874242 | ||
| Persistent activation of coagulation mechanism in unstable angina and myocardial infarction | Q72047945 | ||
| Role of thrombin in endothelial cell monolayer repair in vitro | Q72734000 | ||
| Anticoagulant properties of the vascular endothelium | Q73145742 | ||
| Wear of enhanced ultra-high molecular-weight polyethylene (Hylamer) in combination with a 22.225 mm diameter zirconia femoral head | Q73347452 | ||
| Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation | Q73445675 | ||
| Polymorphonuclear leukocytes modulate tissue factor production by mononuclear cells: role of reactive oxygen species | Q73567365 | ||
| Increased plasma tissue factor levels in acute myocardial infarction | Q73739624 | ||
| Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets | Q73811661 | ||
| Thrombin-induced thromboxane synthesis by human platelets. Properties of anion binding exosite I-independent receptor | Q74070965 | ||
| Platelet-endothelial interactions in inflamed mesenteric venules | Q74138198 | ||
| Tissue factor: an enzyme cofactor and a true receptor | Q74315010 | ||
| The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin | Q74481626 | ||
| Thrombin induces interleukin-6 expression through the cAMP response element in vascular smooth muscle cells | Q77148291 | ||
| Activated platelets and endothelial cell interaction with neutrophils under flow conditions | Q77391112 | ||
| Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils | Q77760114 | ||
| Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina | Q77846342 | ||
| Distinct calcium-dependent pathways of epidermal growth factor receptor transactivation and PYK2 tyrosine phosphorylation in PC12 cells | Q78010436 | ||
| Platelet P-selectin facilitates atherosclerotic lesion development | Q78654773 | ||
| Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells | Q79086335 | ||
| Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice | Q79828506 | ||
| Role of superoxide dismutase in vascular inflammation and in coronary artery disease | Q79840041 | ||
| Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall | Q80512468 | ||
| Structure and function of the plasminogen/plasmin system | Q81668319 | ||
| High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cells | Q82920543 | ||
| Human platelets target dendritic cell differentiation and production of proinflammatory cytokines | Q83314817 | ||
| Relation of platelet count to bleeding and vascular complications in patients undergoing coronary angiography | Q84077201 | ||
| Fibrinolysis: the key to new pathogenetic mechanisms. | Q37160777 | ||
| Blood-borne tissue factor: another view of thrombosis | Q37181879 | ||
| Protease-activated receptors as targets for antiplatelet therapy | Q37223084 | ||
| Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces | Q37352056 | ||
| Endothelial-mural cell signaling in vascular development and angiogenesis | Q37375745 | ||
| Protease-activated receptors in cardiovascular health and diseases | Q37382716 | ||
| B-type natriuretic peptide: endogenous regulator of myocardial structure, biomarker and therapeutic target | Q37622311 | ||
| The lipoprotein-associated coagulation inhibitor | Q37677766 | ||
| VEGF-A: a critical regulator of blood vessel growth | Q37694868 | ||
| Involvement of ERK1/2 kinase in insulin-and thrombin-stimulated vascular smooth muscle cell proliferation | Q37715560 | ||
| Signaling by members of the TGF-beta family in vascular morphogenesis and disease | Q37775374 | ||
| Insulin, thrombine, ERK1/2 kinase and vascular smooth muscle cells proliferation. | Q37821037 | ||
| Thromboxane A2: its generation and role in platelet activation | Q38263211 | ||
| Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. | Q38289775 | ||
| Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets | Q38306581 | ||
| The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells | Q39699871 | ||
| Thrombin promotes proinflammatory phenotype in human vascular smooth muscle cell | Q39706389 | ||
| Thrombin-induced expression of endothelial CX3CL1 potentiates monocyte CCL2 production and transendothelial migration | Q39988367 | ||
| The protease-activated receptor-3 (PAR-3) can signal autonomously to induce interleukin-8 release | Q40014591 | ||
| Natural anticoagulant mechanisms | Q40143046 | ||
| Endothelial-leukocyte adhesion molecules in human disease | Q40389501 | ||
| Long-term aspirin in the prevention of cardiovascular disorders. Recent developments and variations on a theme | Q40423093 | ||
| Interleukin-6 exacerbates early atherosclerosis in mice | Q40793841 | ||
| Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor | Q40867206 | ||
| Vascular endothelial cell activation and permeability responses to thrombin | Q40946084 | ||
| Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. | Q40956616 | ||
| Restenosis following percutaneous revascularization--the potential role of thrombin and the thrombin receptor | Q41148508 | ||
| Alpha-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells | Q41508649 | ||
| Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells | Q41585571 | ||
| Endothelial cells in physiology and in the pathophysiology of vascular disorders | Q41757874 | ||
| The protease-activated receptors and their cellular expression and function in blood-related cells | Q41759322 | ||
| Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation | Q41780031 | ||
| Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo. | Q41835663 | ||
| Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo | Q42044945 | ||
| Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions | Q42101310 | ||
| Activation of protease-activated receptors 3 and 4 accelerates tissue factor-induced thrombin generation on the surface of vascular smooth muscle cells | Q42320997 | ||
| Electromagnetic fields inhibit endothelin-1 production stimulated by thrombin in endothelial cells | Q42485252 | ||
| Thrombin-stimulated elevation of human endothelial-cell cytoplasmic free calcium concentration causes prostacyclin production | Q42516679 | ||
| Regulation of proteinase-activated receptor 1 by inflammatory mediators in human vascular endothelial cells | Q42524907 | ||
| Regulation of functionally active P2Y12 ADP receptors by thrombin in human smooth muscle cells and the presence of P2Y12 in carotid artery lesions. | Q42821507 | ||
| Inhibition of mitogen-activated protein kinase kinase does not impair primary activation of human platelets | Q42983397 | ||
| Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V. | Q42987531 | ||
| Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice | Q43489161 | ||
| Thrombin regulates vascular smooth muscle cell growth and heat shock proteins via the JAK-STAT pathway | Q43559449 | ||
| Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. | Q43562682 | ||
| The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment | Q43684711 | ||
| A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin alpha IIbbeta3. | Q43720106 | ||
| Signalling events underlying platelet aggregation induced by the glycoprotein VI agonist convulxin | Q43770098 | ||
| Modulation of angiogenesis and progelatinase a by thrombin receptor mimetics and antagonists | Q43874428 | ||
| Molecular analysis of axon repulsion by the notochord | Q44304860 | ||
| Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets | Q44403188 | ||
| Inhibition of Platelet-Activating Factor (PAF) Acetylhydrolase by Methyl Arachidonyl Fluorophosphonate Potentiates PAF Synthesis in Thrombin-Stimulated Human Coronary Artery Endothelial Cells | Q44618356 | ||
| Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation. | Q44714830 | ||
| Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gamma T-thrombin. Identification of lysyl residues in alpha-thrombin that are critical for heparin and fibrin(ogen) interactions | Q44844257 | ||
| Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt | Q45029420 | ||
| Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins | Q45182845 | ||
| Role of p38 mitogen-activated protein kinase in thrombus formation | Q45222435 | ||
| Thrombin stimulates smooth muscle cell differentiation from peripheral blood mononuclear cells via protease-activated receptor-1, RhoA, and myocardin | Q45278736 | ||
| Endothelial cells for studies of platelet-activating factor and arachidonate metabolites | Q45743099 | ||
| Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease | Q45878422 | ||
| Transcriptional regulation of the A and B chain genes of platelet-derived growth factor in microvascular endothelial cells. | Q45968786 | ||
| Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT. | Q46001763 | ||
| Thrombin regulates matrix metalloproteinase-9 expression in human monocytes. | Q46005207 | ||
| Primary and secondary capture of platelets onto inflamed femoral artery endothelium is dependent on P-selectin and PSGL-1. | Q46014527 | ||
| Basic and translational research on proteinase-activated receptors: antagonism of the proteinase-activated receptor 1 for thrombin, a novel approach to antiplatelet therapy for atherothrombotic disease | Q46189242 | ||
| Thrombin-stimulated proliferation of cultured human synovial fibroblasts through proteolytic activation of proteinase-activated receptor-1. | Q46372583 | ||
| Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells | Q28581725 | ||
| Tissue factor and hemostasis | Q28630773 | ||
| Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI | Q28631030 | ||
| Elements of the fibrinolytic system | Q28645802 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Adhesion receptors of the immune system | Q29616393 | ||
| Leukotrienes and lipoxins: structures, biosynthesis, and biological effects | Q29617543 | ||
| Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity | Q29617967 | ||
| Thrombin signalling and protease-activated receptors | Q29619601 | ||
| Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits | Q30468424 | ||
| Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis | Q30469144 | ||
| Platelet functions beyond hemostasis | Q33385887 | ||
| Inflammation, sepsis, and coagulation | Q33585742 | ||
| Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines. | Q33720042 | ||
| How the protease thrombin talks to cells | Q33740137 | ||
| Native fibrin gel networks and factors influencing their formation in health and disease. | Q33811728 | ||
| Impaired fibrinolysis in the antiphospholipid syndrome | Q33822542 | ||
| Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. | Q33900013 | ||
| Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin | Q34056920 | ||
| NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis. | Q34074465 | ||
| Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling | Q34108989 | ||
| P2X(1)-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen | Q34150092 | ||
| Minding the gaps to promote thrombus growth and stability | Q34160242 | ||
| Tissue factor, the blood, and the arterial wall | Q34175576 | ||
| Megakaryocytes and beyond: the birth of platelets | Q34215516 | ||
| Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors | Q34251521 | ||
| The platelet release reaction: granules' constituents, secretion and functions | Q34327198 | ||
| The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3‐kinase pathway in maintaining thrombin‐induced platelet aggregation | Q34342288 | ||
| Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin | Q34407094 | ||
| Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells | Q34518795 | ||
| Molecular mechanisms of thrombin-induced endothelial cell permeability | Q34527539 | ||
| Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released | Q34584213 | ||
| Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells | Q34621520 | ||
| VEGF-A and the induction of pathological angiogenesis | Q34718259 | ||
| Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity | Q34775047 | ||
| Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis | Q34828549 | ||
| Heterogeneous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery | Q35042191 | ||
| G-protein coupled receptor antagonists-1: protease activated receptor-1 (PAR-1) antagonists as novel cardiovascular therapeutic agents | Q35137619 | ||
| Biochemistry of Nitric Oxide and Its Redox-Activated Forms | Q35159350 | ||
| Dendritic cells in peripheral tolerance and immunity. | Q35219314 | ||
| Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases | Q35551904 | ||
| The role of the membrane in the expression of the vitamin K-dependent enzymes | Q35564112 | ||
| Regulation of leukocyte transmigration: cell surface interactions and signaling events | Q35612622 | ||
| Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes | Q35682957 | ||
| Reactive oxygen species in vascular biology: role in arterial hypertension | Q35696507 | ||
| Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization | Q35720592 | ||
| P-selectin induces the expression of tissue factor on monocytes | Q35746146 | ||
| Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines | Q35749970 | ||
| Bidirectional relation between inflammation and coagulation | Q35796641 | ||
| Signalling through the platelet glycoprotein Ib-V-IX complex | Q35894162 | ||
| Differing polarity of the constitutive and regulated secretory pathways for von Willebrand factor in endothelial cells | Q36220406 | ||
| Protease-activated receptors in hemostasis, thrombosis and vascular biology | Q36230881 | ||
| Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin | Q36270379 | ||
| Platelets and blood vessels: the adhesion event | Q36286236 | ||
| The interaction of thrombin with blood platelets | Q36291249 | ||
| The interactions between inflammation and coagulation | Q36310877 | ||
| Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells | Q36436399 | ||
| Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice | Q36447954 | ||
| Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system | Q36492944 | ||
| Dendritic cells: translating innate to adaptive immunity. | Q36627111 | ||
| Leucocyte cellular adhesion molecules | Q36633473 | ||
| Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways | Q36647303 | ||
| The roles of proteinase-activated receptors in the vascular physiology and pathophysiology. | Q36649442 | ||
| Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis | Q36660105 | ||
| Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice | Q36853413 | ||
| The FGF system has a key role in regulating vascular integrity | Q36861249 | ||
| Platelet activation and atherothrombosis | Q37031278 | ||
| Platelet chemokines in vascular disease | Q37131719 | ||
| Mature dendritic cells express functional thrombin receptors triggering chemotaxis and CCL18/pulmonary and activation-regulated chemokine induction. | Q46497438 | ||
| Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans | Q46614700 | ||
| Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells. | Q46830533 | ||
| Thrombin regulates the function of human blood dendritic cells | Q46940799 | ||
| The size of human factor VIII heterodimers and the effects produced by thrombin | Q47207667 | ||
| Mechanism of endothelium-dependent relaxation induced by thrombin in the pig coronary artery | Q47711198 | ||
| Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells | Q47835116 | ||
| Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin | Q47869831 | ||
| Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys | Q48877475 | ||
| Maturity and fertility of rhesus monkey oocytes collected at different intervals after an ovulatory stimulus (human chorionic gonadotropin) in in vitro fertilization cycles | Q49026420 | ||
| Selective recruitment of neutrophils and lymphocytes by thrombin: a role for NF-kappaB. | Q49227852 | ||
| Protease-activated receptors upregulate cyclooxygenase-2 expression in human endothelial cells. | Q50281727 | ||
| Platelet response heterogeneity in thrombus formation. | Q50284450 | ||
| Thrombin binding to GPIbalpha induces platelet aggregation and fibrin clot retraction supported by resting alphaIIbbeta3 interaction with polymerized fibrin | Q50331347 | ||
| Comparison of plasma tissue factor levels in unstable and stable angina pectoris. | Q50908719 | ||
| Proliferation of dental pulp fibroblasts in response to thrombin involves mitogen-activated protein kinase signalling. | Q51052801 | ||
| Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. | Q52114386 | ||
| The role of the tissue factor pathway in initiation of coagulation. | Q52231388 | ||
| Platelet factor Xa receptor | Q52434023 | ||
| Receptor mechanism of thrombin-induced endothelium-dependent and endothelium-independent coronary vascular effects in dogs. | Q52507277 | ||
| Mechanism of endothelial nitric oxide synthase phosphorylation and activation by thrombin. | Q53578656 | ||
| Thrombin induces EGF receptor expression and cell proliferation via a PKC(delta)/c-Src-dependent pathway in vascular smooth muscle cells. | Q54730744 | ||
| Platelet, Not Endothelial, P-Selectin Is Required for Neointimal Formation After Vascular Injury | Q56944225 | ||
| Actions of Thrombin and Other Coagulant and Proteolytic Enzymes on Blood Platelets | Q59057847 | ||
| MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions | Q59064735 | ||
| Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets | Q59065667 | ||
| Direct Vascular Effects of Protease-Activated Receptor Type 1 Agonism In Vivo in Humans | Q63488636 | ||
| Time course of recovery of endothelial cell surface thrombin receptor (PAR-1) expression. | Q64960495 | ||
| The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity | Q67469084 | ||
| Thrombin-catalyzed activation of single chain bovine factor V | Q67469113 | ||
| Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro | Q67913706 | ||
| Functional difference between intrinsic and extrinsic coagulation pathways. Kinetics of factor X activation on human monocytes and alveolar macrophages | Q67987137 | ||
| Thrombin enhances release of tissue plasminogen activator from bovine corneal endothelial cells | Q69212170 | ||
| Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells | Q69535502 | ||
| Thrombin-induced chemotaxis and aggregation of neutrophils | Q69593060 | ||
| Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity | Q69843451 | ||
| A pathway of coagulation on endothelial cells | Q69874615 | ||
| Endothelium and the regulation of coagulation | Q70015651 | ||
| Human prothrombinase complex assembly and function on isolated peripheral blood cell populations | Q70060804 | ||
| Subunit structure of thrombin-activated human factor VIIIa | Q70372881 | ||
| Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy | Q70824082 | ||
| Macrophages and neutrophils infiltrating into the liver are responsible for tissue factor expression in a rabbit model of acute obstructive cholangitis | Q71307865 | ||
| Monocyte chemotaxis: stimulation by specific exosite region in thrombin | Q71695951 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 301-313 | |
| P577 | publication date | 2011-08-23 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | Thrombin and vascular inflammation | |
| P478 | volume | 359 |
| Q91807391 | 2-Arylidene-1-indandiones as Pleiotropic Agents with Antioxidant and Inhibitory Enzymes Activities |
| Q35723731 | A review of the pathophysiology and potential biomarkers for peripheral artery disease. |
| Q39334944 | Bicyclic peptide inhibitor of urokinase-type plasminogen activator: mode of action |
| Q30803044 | CCN1/CYR61-mediated meticulous patrolling by Ly6Clow monocytes fuels vascular inflammation |
| Q36732743 | Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen |
| Q39608861 | Enhanced P-selectin expression on platelet-a marker of platelet activation, in young patients with angiographically proven coronary artery disease |
| Q37334725 | Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation |
| Q38299278 | Highly sensitive detection for proteins using graphene oxide-aptamer based sensors |
| Q46804764 | Highly sensitive protein detection via covalently linked aptamer to MoS2 and exonuclease-assisted amplification strategy |
| Q39145518 | Improved adhesion and differentiation of endothelial cells on surface-attached fibrin structures containing extracellular matrix proteins. |
| Q26997381 | Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases |
| Q38103051 | Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. |
| Q39686103 | MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10. |
| Q38129719 | Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond |
| Q89766701 | Phosphoproteomic analysis of protease-activated receptor-1 biased signaling reveals unique modulators of endothelial barrier function |
| Q36129629 | Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold. |
| Q34168176 | RNA-seq reveals novel transcriptome of genes and their isoforms in human pulmonary microvascular endothelial cells treated with thrombin |
| Q36887349 | RhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell border |
| Q38047647 | Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases |
| Q26775993 | Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation |
| Q39385967 | Targeting activated protein C to treat hemophilia. |
| Q48114969 | The Role of Gap Junction-Mediated Endothelial Cell-Cell Interaction in the Crosstalk between Inflammation and Blood Coagulation. |
| Q39344700 | Thrombin Cleavage of Inter-α-inhibitor Heavy Chain 1 Regulates Leukocyte Binding to an Inflammatory Hyaluronan Matrix |
| Q98879504 | Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19 |
| Q89494130 | Thrombin as Key Mediator of Seizure Development Following Traumatic Brain Injury |
| Q42589170 | Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis |
Search more.